文献速递流行病学与生物统计真实世界研究与卫生经济

南非差异化抗病毒治疗交付模式:依从性俱乐部与分散药物发放的整群随机评估

Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
PubMed 文献 · PLoS Med · 2019-07-23

本研究在南非24家机构评估依从性俱乐部(AC)和分散药物发放(DMD)两种差异化抗病毒治疗交付模式。AC患者1年保留率高于对照(89.5% vs 81.6%,aRD 8.3%,95%CI 1.1%–15.6%),病毒抑制相当;DMD保留率数值较低但结果不精确,病毒抑制与标准护理相当。

要点

  • AC可提高稳定期患者1年保留率,病毒抑制与标准护理相当。
  • DMD与标准护理相比,保留和病毒抑制结果相当但估计不精确。
  • 男性在AC和DMD中均显示保留或病毒抑制的潜在获益。

核心结论

  • AC与标准护理相比提高1年保留率,病毒抑制相当。
  • DMD与标准护理相比保留和病毒抑制结果相当但估计不精确。
  • 男性在AC保留和DMD病毒抑制方面显示潜在获益。

研究设计与样本

  • 在南非4省24家机构开展整群随机评估,12家干预、12家对照。
  • AC分析纳入干预275例、对照294例;DMD分析纳入干预232例、对照346例。
  • AC采用整群随机比较;DMD随机未保留,按观察性分析处理。
  • 主要结局为入组后12个月保留和持续病毒抑制(<400 copies/mL)。

主要发现

  • AC患者1年保留率89.5% vs 对照81.6%,aRD 8.3%(95%CI 1.1%–15.6%)。
  • AC患者1年持续病毒抑制80.0% vs 79.6%,aRD 3.8%(95%CI -6.9%–14.4%)。
  • DMD患者1年保留率81.5% vs 87.2%,aRD -5.9%(95%CI -12.5%–0.8%)。
  • DMD患者病毒抑制77.2% vs 74.3%,aRD -1.0%(95%CI -12.2%–10.1%)。
  • AC男性保留RD 13.1%(95%CI 0.3%–23.5%),女性RD 6.0%(95%CI -0.9%–12.9%)。

关键数值与推荐

  • AC患者1年保留aRD 8.3%(95%CI 1.1%–15.6%)。
  • AC患者1年持续病毒抑制aRD 3.8%(95%CI -6.9%–14.4%)。
  • DMD患者1年保留aRD -5.9%(95%CI -12.5%–0.8%)。
  • DMD患者病毒抑制aRD -1.0%(95%CI -12.2%–10.1%)。
  • DMD男性病毒抑制RD 11.1%(95%CI -3.4%–25.5%)。

临床怎么用

  • AC可作为稳定期患者提高保留率的差异化服务模式。
  • DMD结果不精确,实施需结合本地条件评估。
  • 男性患者可考虑替代服务交付模式以改善结局。
  • 社区策略可减轻基层医疗机构拥挤并减少患者不便。

局限性

  • 存在缺失数据。
  • DMD分析未保留随机化,按观察性分析处理。
  • DMD相关估计不精确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differentiated antiretroviral therapy (ART) delivery models, in which patients are provided with care relevant to their current status (e.g., newly initiating, stable on treatment, or unstable on treatment) has become an essential part of patient-centered health systems. In 2015, the South African government implemented Chronic Disease Adherence Guidelines (AGLs), which involved five interventions: Fast Track Initiation Counseling for newly initiating patients, Enhanced Adherence Counseling for patients with an unsuppressed viral load, Early Tracing of patients who miss visits, and Adherence Clubs (ACs) and Decentralized Medication Delivery (DMD) for stable patients. We evaluated two of these interventions in 24 South African facilities: ACs, in which patients meet in groups outside usual clinic procedures and receive medication; and DMD, in which patients pick up their medication outside usual pharmacy queues. METHODS AND FINDINGS: We compared those participating in ACs or receiving DMD at intervention sites to those eligible for ACs or DMD at control sites. Outcomes were retention and sustained viral suppression (<400 copies/mL) 12 months after AC or DMD enrollment (or comparable time for controls). 12 facilities were randomly allocated to intervention and 12 to control arms in four provinces (Gauteng, North West, Limpopo, and KwaZulu Natal). We calculated adjusted risk differences (aRDs) with cluster adjustment using generalized estimating equations (GEEs) using difference in differences (DiD) with patients eligible for ACs/DMD prior to implementation (Jan 1, 2015) for comparison. For DMD, randomization was not preserved, and the analysis was treated as observational. For ACs, 275 intervention and 294 control patients were enrolled; 72% of patients were female, 61% were aged 30-49 years, and median CD4 count at ART initiation was 268 cells/μL. AC patients had higher 1-year retention (89.5% versus 81.6%, aRD: 8.3%; 95% CI: 1.1% to 15.6%) and comparable sustained 1-year viral suppression (<400 copies/mL any time ≤ 18 months) (80.0% versus 79.6%, aRD: 3.8%; 95% CI: -6.9% to 14.4%). Retention associations were apparently stronger for men than women (men RD: 13.1%, 95% CI: 0.3% to 23.5%; women RD: 6.0%, 95% CI: -0.9% to 12.9%). For DMD, 232 intervention and 346 control patients were enrolled; 71% of patients were female, 65% were aged 30-49 years, and median CD4 count at ART initiation was 270 cells/μL. DMD patients had apparently lower retention (81.5% versus 87.2%, aRD: -5.9%; 95% CI: -12.5% to 0.8%) and comparable viral suppression versus standard of care (77.2% versus 74.3%, aRD: -1.0%; 95% CI: -12.2% to 10.1%), though in both cases, our findings were imprecise. We also noted apparently increased viral suppression among men (RD: 11.1%; 95% CI: -3.4% to 25.5%). The main study limitations were missing data and lack of randomization in the DMD analysis. CONCLUSIONS: In this study, we found comparable DMD outcomes versus standard of care at facilities, a benefit for retention of patients in care with ACs, and apparent benefits in terms of retention (for AC patients) and sustained viral suppression (for DMD patients) among men. This suggests the importance of alternative service delivery models for men and of community-based strategies to decongest primary healthcare facilities. Because these strategies also reduce patient inconvenience and decongest clinics, comparable outcomes are a potential success. The cost of all five AGL interventions and possible effects on reducing clinic congestion should be investigated. CLINICAL TRIAL REGISTRATION: NCT02536768.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Fox MP, Pascoe S, Huber AN, et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. PLoS Med. 2019. PMID: 31335865. doi:10.1371/journal.pmed.1002874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。